Inflammation meetings & conferences

Inducing and Breaking Tolerogenic Antigen-Presenting Cell Function

Thursday, 5 July 2012 London, United Kingdom

Professional antigen-presenting cells (APC) such as dendritic cells (DC) and macrophages play a critical role in the initiation and maintenance of a T cell-mediated immune response. APC are essential for T cell priming, differentiation and activation in lymphoid tissue and at sites of inflammation. Understanding the molecular mechanisms via which APC function can be controlled may give novel insights into how T cell mediated immunity may be induced or blocked. This meeting will highlight current research aimed at inducing APC with tolerogenic function in order to treat inflammatory disease (e.g. rheumatoid arthritis) as well as work aimed at boosting the immunostimulatory function of APC in the context of cancer. The meeting will also highlight recent progress on the suppressive effects of CD4+ regulatory T cells on APC function, and how these can be overcome.

This event has CPD accreditation and will have a discussion panel session.

On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event

Meeting chairs: Dr Leonie Taams, Senior Lecturer in Immunology, King's College London Centre for Molecular and Cellular Biology of Inflammation and Dr Catharien Hilkens, Reader in Immunotherapy, Newcastle University , UK

Email: enquiries@euroscicon.com

Web: www.euroscicon.com

For all accommodation and travel enquiries please contact accommodationandtravel@euroscicon.com

The Lung – a Pivotal Player in Systemic Inflammatory Disorders

June 11-12, 2012 Solna, Sweden

As representatives of the Executive Committee and Advisory Board of this symposium we are happy to invite you to participate in this unique symposium on systemic inflammatory disorders. It is arranged by representatives from both clinic and research, and by specialists in pulmonary medicine, rheumatology and neurology enabling fruitful information and discussions on general topics as well as on specific issues. The high quality of the meeting is reflected by the use of the trade mark “Karolinska Institutet Conferences”, and internationally well recognized speakers further guarantee that interesting data will be presented.

The symposium is arranged as a result of recent data on how smoking and genetic factors have a great impact not only on the lungs but also on other organs affected in systemic inflammatory disorders. These findings call for more intensive collaborations in the future between clinicians representing different specialties’ and for research of truly translational character.

Introductory speeches will be given to inform about common clinical findings which may reflect lung involvement in systemic disorders, and how they can be established. Smoking and co-morbidity in systemic inflammatory disorders will be discussed, and the role of interstitial lung involvement in myositis, rheumatoid arthritis and multiple sclerosis will be elucidated. Can smoking related changes in the lung trigger joint inflammation, or increase the risk of getting myositis or MS? Another topic is the genetic and possible etiological background in sarcoidosis.

Up-to-date treatment of interstitial lung involvement, pros and cons, and the effects of smoking on treatment will be debated followed by an overview of failures and successes of smoking cessation programs.

You will also at a poster-viewing session be given the opportunity to informally discuss your own abstract. Can you really afford not to participate?

Congrex Sweden AB
Attn: The Lung

Telephone/fax
T: +46 8 459 66 00
F: +46 8 661 91 25

General requests
thelung2012@congrex.com
Registration and hotel matters
thelung2012.registration@congrex.com

Temporomandibular Joint Disorder Bioengineering Conference

Thursday September 20 through Saturday September 22, 2012 Pittsburgh, Pennsylvania.

The meeting will provide a unique opportunity for bioengineers, clinicians and scientists to discuss the challenges presented by temporomandibular joint disorders, and to devise strategies to address those challenges.

Objectives

The overall meeting objective is to organize a scientific conference exclusively dedicated to the TMJ, and to advance the field of TMJ research and strengthen the continuity among clinicians, scientists and bioengineers in this pursuit.

This overall objective will be addressed by the following specific objectives:

Provide recommendations to the NIDCR TMJD Program on novel scientific approaches and critical research topics that will advance the field.
Establish a benchmark for current treatments and scientific knowledge.
Bring outside perspective from experts in areas pertinent to TMJ research.

You Should Attend If…

You are not currently in TMJ research, but are looking for new and relatively unexplored funding areas where you can apply your research strengths.
You are currently a TMJ researcher and want to keep up with the latest advances in the field.
You are looking for collaborators in TMJ research.
You are a bioengineer, and want to know the practical needs of surgeons and patients.
You are a clinician, and want to understand the capabilities of the engineering community.

For more information on the conference, contact

Alejandro J. Almarza, Ph.D.
Conference Chair
566 Salk Hall
3501 Terrace Street, 15261
(412) 648-15243
aja19@pitt.edu
University of Pittsburgh
Pittsburgh, PA

3rd World Psoriasis & Psoriatic Arthritis Conference 2012

June 27 July 1, 2012 Stockholm, Sweden

“Psoriasis a global health challenge”

In 2012 the International Federation of Psoriasis Associations (IFPA) will be holding the World Psoriasis & Psoriatic Conference in Stockholm for the third time, in cooperation with leading dermatologists and rheumatologists. The purpose of the conference is to elucidate the disease from a number of scientific aspects. At the first conference, in 2006, the focus was on clarifying the connection between psoriasis of the skin and psoriatic arthritis. At the second conference, in 2009, we moved on to present an aggregated picture of psoriasis as a complex, chronic, inflammatory disease that can affect several of the body’s organs through a number of co-morbidities.

For this upcoming conference we have even further deepened the cooperation between IFPA and the medical profession, and a number of new areas will be covered which will improve the understanding and care of psoriasis patients, such as the psychosocial impact on quality of life.

The scientific program will also, as before, be strongly influenced by IFPA’s worldwide member survey, to ensure that the patient’s perspective is included. As with the 2009 conference, there will also be special seminars and side tracks for nurses, allied health professionals and others, who have a most important role in the care of psoriasis patients. This complementary program is arranged in cooperation with the International Skin care Nursing Group (ISNG).

CONTACT
Conference organizer
Congrex Sweden AB
psoriasis2012@congrex.com
www.congrex.com

Phone: +46 8 459 66 00
Fax: + 46 8 661 91 25

IFPA Secretariat
Box 5173
SE-121 18 Johanneshov
SWEDEN
Phone: +46 8 556 109 14
Fax: +46 8 556 109 19
E-mail: ifpa@pso.se
www.ifpa-pso.org

International Symposium on Ocular Pharmacology and Therapeutics ISOPT Clinical 2013

March 7-10, 2013 Paris, France

ISOPT will reconvene in Paris March 7 – 10 for our 10th symposium. Over the years, ISOPT has repeatedly shaped its form so it can accommodate to provide a collaborative atmosphere for clinicians, clinical trialists, pharma industry and regulatory officers. Our formed vision has been to increase knowledge and awareness of drug usage in ophthalmology reflecting innovations and their utilization in practice. In order to achieve this vision ISOPT is set to implement the following missions:

Educate via updating and sharing current and evolving treatment algorithms for practitioners.

Connect data arising from clinical studies to actual daily practice.

Facilitate innovation via panels and discussions of early and late “development related topics”.

We invite you to join us in Paris, and become a part of ISOPT, bring your own experience and insights of treating your patients, be exposed to the last two year clinical experience gained in major industry supported studies and be part of the efforts to reflect scientific data to clinical reality and patient care.

ISOPT has become famous for its informal atmosphere and the ability to meet experts and faculty leaders for “out of the lecture hall” discussions.

Whether your field of interest is in retinal diseases, inflammation, cornea and external diseases, glaucoma or basic science you may contribute and be part of the ISOPT spirit.

Focused Update in Medical Management

Retina

Dry AMD

Wet AMD

Diabetic Retinopathy

Diabetic Macular Edema

Retinal Vein Occlusion

Retinal Degeneration

Devices & Drug Delivery

Inflammation & Infection
Allergic Conjunctivitis

Treatment Updates

Clinical Studies for Uveitis

Cases Presentation

Ocular Infections

Basic Science

Therapy of Neovascularization

Inhibition of Diabetic Retinopathy

Antioxidants and Nutrition

Vascular Targets

Gene Therapy

Glaucoma

Conventional & Potential Glaucoma Therapy

Glaucoma Therapy & Ocular Surface

Inraocular Pressure & Glaucoma

Blood Flow & Glaucoma

External Eye Diseases
Dry Eye Treatment Innovations

Dry Eye-Ocular Surface Clinical Trials

Wound Healing

External Eye Diseases

Anterior Segment Imaging

Devices

Drug Development

Drug Delivery

Imaging

Toxicology

Nano Technology

Regulation of Ophthalmic Products

Ethics

A platform for informal communication with experts in drug development

Symposium Secretariat

Paragon Conventions
18, Avenue Louis-Casai
1209 Geneva, Switzerland
Tel: +41 (0)22 5330 948
Fax: +41 (0)22 5802 953
Email: isopt@isopt.net

 55th Annual Thomas L. Petty Aspen Lung Conference

“Mechanics and Mechanisms of Pulmonary Hypertension”

June 6-9, 2012 Aspen, Colorado

The theme of the 55th Meeting of the Thomas L. Petty Aspen Lung Conference is “Mechanics and Mechanisms of Pulmonary Hypertension”. Emphasizing the integration of basic, translational and clinical sciences, the meeting will focus on the utilization of new strategies and technologies to investigate the pathogenesis, treatments and outcomes of pulmonary hypertension. Anchored by twelve “state-of-the-art” presentations delivered by international experts with accompanying abstract presentations, the thematic sessions will address epidemiology, progenitor cell biology, the role of inflammation, genetic somatic mutations and epigenetics, the impact of right ventricle (RV) dysfunction and RV-pulmonary artery coupling, the etiology and implication of PAH in WHO class III disease and prospects for novel disease modifying and preventive therapies. The Conference Summary will be presented by Werner Seeger, M.D., Professor of Medicine, Chief of the Department of Internal Medicine at the University Giessen Hospital, Germany. Dr. Seeger is Chairman of the Lung Center, and the Director of the Max Planck Institute for Heart and Lung Research and one of the world’s preeminent experts in the field of pulmonary vascular disease.

For more information, contact:

Todd Bull, M.D., c/o Jeanne Cleary
Thomas L. Petty Aspen Lung Conference
Anschutz Medical Campus, Research 2, Box C272, 9th Floor
12700 East 19th Avenue, Aurora, CO 80045
Phone: (303) 358-2797. Fax: (720) 851-1034. E-Mail:
Jeanne.Cleary@ucdenver.edu

or visit our website at
www.aspenlungconference.org
 

3rd International Congress on Abdominal Obesity

July 9-12, 2012 Québec City, Québec, Canada

The 3rd International Congress on Abdominal Obesity (ICAO 2012) is a highly anticipated event that will build on the success of last year’s Congress, held in Buenos Aires, Argentina. The Congress’s primary objective is to bring together medical professionals from all specialties to exchange ideas and information and raise awareness of abdominal obesity as a new modifiable risk factor which, along with traditional risk factors, plays a central role in this new concept of global cardiometabolic risk.

This relatively new Congress’s innovative multidisciplinary approach has facilitated the development of a new medical paradigm, whereby complications as hypertension, dyslipidemia, type 2 diabetes, and cardiovascular disease are no longer evaluated and treated in isolation.

We look forward to seeing you in Québec City, Québec, Canada, for what promises to be an exciting and cutting edge gathering of medical professionals of varied interests and backgrounds.

Abstract Topics

Abdominal Obesity/Body Fat Distribution
Acute Coronary Syndromes
Adipokines
Adipose Tissue
Cardiometabolic Risk
Cardiovascular Disease
Childhood Obesity
Clinical Cardiology
Clinical Trials
Diabetes
Ectopic Fat
Epidemiology
Ethnicity
Gender Differences
Genetics
Hypertension
Inflammation
Insulin Resistance
Interventional Cardiology
Lipids/Lipoproteins
Metabolic Syndrome
Nutrition
Obesity
Pathophysiology/Basic Science/Animal Studies
Pathophysiology/Clinical Science/Human Studies
Physical Activity/Exercise
Prevention
Smoking
Steroid Hormones
Thrombosis

Contact Us

Kenes International
1-3 Rue de Chantepoulet
PO Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
Email: icao@kenes.com

XX Biennial Meeting of the International Society for Eye Research

July 21-25, 2012 Berlin, Germany

The XX Biennial Meeting of the International Society for Eye Research will present clinicians and vision researchers from all over the world with the latest scientific achievements and research in the field. During a stimulating scientific program, world leading researchers will cover a broad range of specialist and general topics in a series of lectures and poster sessions. The event promotes international research cooperation by providing participants with a platform to share their latest findings, technical expertise and experience.

Topics
Section Topics

Cornea and Ocular Surface
Glaucoma
Immunology and Inflammation
Lens
Ophthalmic Pathology

Physiology and Pharmacology
Refraction and Physiological Optics
Retinal Cell Biology
Retinal Neuroscience
Strabismus and Amblyopia

Preliminary Session Topics
Cornea and Ocular Surface

Italian-German Young Investigator Symposium: Future Strategies in Diagnosis and Therapy of Ocular Surface

Role of TSP-1 in ocular pathology

TGF Beta Induced Proteins In The Cornea

Translational Aspects Of Anti(Lymph)Angiogenic Therapy At The Ocular Surface

Corneal Regenerative Medicine

Ocular Innervation in Ocular Pathologies

Neurotrophic Keratopathy

Myofibroblast Biology And Pathobiology In The Cornea After Injury Or Surgery

Dry Eye Syndromes: Pathogenesis, Biomarkers, and Beyond

Update: Ocular Surface Imaging

Deep Anterior Lamellar Keratoplast
Glaucoma

Trabecular Meshwork

Local Signaling in Conventional Outflow Pathway

What is the best animal model for glaucoma?

Imaging

Rho Kinase Inhibitors

Identified Players in Glaucoma

Inner Wall of Schlemm's canal

Neuroprotection in the Retina

Mechanisms of Neuroprotection

Role of Astrocytes

Genetics

Vascular Component in Glaucoma

IOP, EVP, CSF

*Optic Nerve Biomechanics

Biomarkers

*Current Concepts in Pathophysiology of Glaucomas
Immunology and Inflammation

Microbial Pathogenesis

Ocular Infection, Inflammation and Immunity

Translating Advances in the Immunology Lab to the Clinic

Macrophages and Microglial Regulation of Ocular Inflammation

Microglial Activation in Retinal Degeneration

Immunology of Dry Eye
Lens

Lens Genetics

Molecular Mechanisms of Lens Lineage Formation

Eye Development, Tissue Interactions and Evolution

Lens Morphogenesis

Fiber Cell Structure Meets Lens Function

Crystallin Function

Crystallin Post-Translational Modifications

Lens Cytoskeleton/Membrane Structure

Epidemiology Meets Environmental and Age Related Changes in the Lens

Oxidative Stress: Damage, Defense and Repair

Ocular Aging: Normal Events and Their Contribution to Disease

Posterior Capsular Opacification

Crystallins Outside of the Lens

Lens Cell Communication- The Control of Communication between Lens Cells Allowing For the Function of This Avascular Tissue
Ophthalmic Pathology

Future Therapies in Ocular Oncology

Stem Cells and Ocular Surface Regeneration

The Choroidal Vasculature in Disease States

Tissue Engineering of Ocular Diseases

*Current Concepts in Pathophysiology of Glaucomas
Physiology and Pharmacology

Autophagy

Channelrhodopsine/Optogenetic

Mechanical stimuli

Aqueous dynamics

Blood Flow

Drug Discovery/Design/Development

*Optic Nerve Biomechanics

Angiotensin

Nanoparticles

Bestrophin

Oxygen in the Eye: Friend or Foe

Electrostimulation
Refraction and Physiological Optics

Wavefrontcorrection and Customized Implants

New Concepts in Aspherical, Multifocal and ToricIOL Implants

1D, 2D and 3D Optical Imaging of the Eye (or Anterior Eye Segment)
Retinal Cell Biology

Complex Eye Diseases - Research (Diabetic Retinopathy and AMD)

Regulation of Retinal Rhythms: From Photoreceptor Metabolism to Disc Shedding

New Gene and Cell Based Treatments Strategies of Retinal Diseases

Is diabetic retinopathy an inflammatory disease?

Contribution of Apoptosis to the Biology of Ocular Cells in Health and Disease

Oxidative Stress and Retina Degeneration

Retinal Angiogenesis

Retinal and Choroidal Development

Photoreceptor Cell Death Mechanisms and Avenues for Neuroprotection

Nuclear Receptors and their Role in the Retina and in AMD

Neuroprotection

Reactive Muller Glia: Friend or Foe?

Nuclear Receptors and their Role in AMD and the Retina
Retinal Neuroscience

Dynamics and Stability of Retinal Processing

The Syncytial Retina

The Zebrafish Retina

Gene- and Cell-based Strategies for the Treatment of Retinal Degeneration

Evolution of vVsion

Phototransduction

Retinal Remodeling

Membrane Protein Transport in Photoreceptors/RPE

Ribbon Synapses

TRP Channels and Bipolar Cells

Strabismus and Amblyopia

Strabism

Albinism

Amblyopia

ISER 2012 Meeting Secretariat

Kenes International
C/o Kenes International
1-3, Rue de Chantepoulet,
P.O. Box 1726
CH-1211 Geneva 1 Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
E-mail: iser@kenes.com

Society for Leukocyte Biology 2012 45th Annual Meeting: Inflammation in Innate and Adaptive Immune Mechanisms

October 28 - 30, 2012 Maui, Hawai'i

Organizers: Tom Hamilton and Xiaoxia Li

Society for Leukocyte Biology
9650 Rockville Pike
Bethesda, MD 20814
P: 301-634-7814
F: 301-634-7455
slb@faseb.org